ING Groep NV reduced its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 20.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 28,311 shares of the biopharmaceutical company’s stock after selling 7,484 shares during the period. ING Groep […]
Regeneron Pharmaceuticals (NASDAQ:REGN) Receives New Coverage from Analysts at Evercore ISI tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Insider Selling: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Insider Sells 16,848 Shares of Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cannell & Co. Reduces Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cozad Asset Management Inc. Has $3.20 Million Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.